Feb 15 (Reuters) – The U.S. governing administration must encounter a patent lawsuit in excess of COVID-19 vaccines, not vaccine maker Moderna Inc (MRNA.O), the Division of Justice explained to a Delaware federal court docket on Tuesday. The Justice Department’s court submitting said the United States ought to be liable for any infringement of Arbutus Biopharma Corp (ABUS.O) and Genevant Sciences GmbH’s patents that took location under Moderna’s contract to provide pictures for the government’s nationwide vaccination exertion. Moderna made the very same argument final calendar year in an unsuccessful bid to earn an early dismissal of the lawsuit. Genevant declined to comment on the filing. Representatives for Moderna, the…